Your browser doesn't support javascript.
loading
A Randomized, Placebo-Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High-Density Lipoprotein Cholesterol in Subjects With Dyslipidemia.
Olson, Eric J; Mahar, Kelly M; Haws, Thomas F; Fossler, Michael J; Gao, Feng; de Gouville, Anne-Charlotte; Sprecher, Dennis L; Lepore, John J.
Afiliação
  • Olson EJ; Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Collegeville, PA, USA.
  • Mahar KM; Clinical Pharmacology, Modeling and Simulation, GlaxoSmithKline, Collegeville, PA, USA.
  • Haws TF; Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Collegeville, PA, USA.
  • Fossler MJ; Clinical Pharmacology, Modeling and Simulation, GlaxoSmithKline, Collegeville, PA, USA.
  • Gao F; Clinical Statistics, Metabolic Pathways and Cardiovascular Unit, GlaxoSmithKline, Collegeville, PA, USA.
  • de Gouville AC; GlaxoSmithKline Laboratories, Centre de Recherche François Hyafil, Les Ulis Cedex, France.
  • Sprecher DL; Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Collegeville, PA, USA.
  • Lepore JJ; Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Collegeville, PA, USA.
Clin Pharmacol Drug Dev ; 8(7): 871-883, 2019 10.
Article em En | MEDLINE | ID: mdl-31268250
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Xantinas / Dislipidemias / Rubor / HDL-Colesterol Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Xantinas / Dislipidemias / Rubor / HDL-Colesterol Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos